Related Experiment Videos
Bilateral neuralgic amyotrophy induced by interferon treatment
P L Bernsen1, R E Wong Chung, H M Vingerhoets
1Institute of Neurology, St Radboud University Hospital, Nijmegen, The Netherlands.
Archives of Neurology
|April 1, 1988
Summary
Recombinant interferon therapy can cause focal neurologic side effects, including neuralgic amyotrophy and radicular irritation, in patients with hairy cell leukemia. These neurological disturbances may occur alongside diffuse central and peripheral nervous system involvement.
Area of Science:
- Neurology
- Oncology
- Immunology
Background:
- Interferon therapy is a common treatment for hematologic malignancies like hairy cell leukemia.
- Neurologic side effects of interferon are typically diffuse, affecting the central and peripheral nervous systems.
- Focal neurologic disturbances are less commonly reported but can occur.
Observation:
- A patient with hairy cell leukemia developed bilateral neuralgic amyotrophy and sacral radicular irritation during recombinant interferon treatment.
- The patient also experienced worsening of a pre-existing polyneuropathy.
- Cerebrospinal fluid analysis revealed elevated protein and oligoclonal banding.
Findings:
- The case demonstrates that interferon therapy can induce focal neurologic complications, such as neuralgic amyotrophy.
- Mees-Beau lines on fingernails were observed weeks after discontinuing interferon, suggesting a potential link.
- These findings align with other reports indicating interferon's capacity to cause focal neurological issues.
Implications:
- Clinicians should be aware of the potential for focal neurologic side effects during interferon therapy.
- Early recognition and management of these neurological disturbances are crucial for patient outcomes.
- Further research is warranted to understand the mechanisms behind interferon-induced focal neuropathies.